Literature DB >> 10506661

Osteopontin is an autoantigen of the somatostatin cells in human islets: identification by screening random peptide libraries with sera of patients with insulin-dependent diabetes mellitus.

A Fierabracci1, P A Biro, Y Yiangou, C Mennuni, A Luzzago, J Ludvigsson, R Cortese, G F Bottazzo.   

Abstract

Random peptide libraries (RPLs) screening with IDDM sera has identified 5 disease-specific 'mimotopes' displayed on phage (phagotopes). We characterised one phagotope (CH1p), by raising a rabbit antibody against the peptide insert on phage, which was employed in immunohistochemistry, Western blotting and cDNA libraries screening. The CH1p mimotope was detected in somatostatin cells of human islets and experimentally raised anti-osteopontin antibodies or human sera positive for the phagotope, detected a similar subpopulation of islet cells. The screening of cDNA library identified a clone corresponding to human osteopontin. In summary, RPLs proved to be successful in the identification of a novel islet-related autoantigen (osteopontin), whose significance in disease remains to be established.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10506661     DOI: 10.1016/s0264-410x(99)00204-2

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  7 in total

1.  An update on the use of NOD mice to study autoimmune (Type 1) diabetes.

Authors:  Rodolfo José Chaparro; Teresa P Dilorenzo
Journal:  Expert Rev Clin Immunol       Date:  2010-11       Impact factor: 4.473

2.  The immunohistochemical expression profile of osteopontin in normal human tissues using two site-specific antibodies reveals a wide distribution of positive cells and extensive expression in the central and peripheral nervous systems.

Authors:  Yasuto Kunii; Shin-ichi Niwa; Yoshiaki Hagiwara; Masahiro Maeda; Tsutomu Seitoh; Toshimitsu Suzuki
Journal:  Med Mol Morphol       Date:  2009-09-26       Impact factor: 2.309

3.  Osteopontin is a novel marker of pancreatic ductal tissues and of undifferentiated pancreatic precursors in mice.

Authors:  Gamze Kilic; Junfeng Wang; Beatriz Sosa-Pineda
Journal:  Dev Dyn       Date:  2006-06       Impact factor: 3.780

4.  The Role of Osteopontin in the Pathogenesis and Complications of Type 1 Diabetes Mellitus in Children.

Authors:  Mohamed A Talat; Laila Metwaly Sherief; Hosam Fathy El-Saadany; Anwar Ahmed Rass; Rabab M Saleh; Maha Mahmoud Hamed Sakr
Journal:  J Clin Res Pediatr Endocrinol       Date:  2016-06-29

Review 5.  Osteopontin Bridging Innate and Adaptive Immunity in Autoimmune Diseases.

Authors:  Nausicaa Clemente; Davide Raineri; Giuseppe Cappellano; Elena Boggio; Francesco Favero; Maria Felicia Soluri; Chiara Dianzani; Cristoforo Comi; Umberto Dianzani; Annalisa Chiocchetti
Journal:  J Immunol Res       Date:  2016-12-20       Impact factor: 4.818

Review 6.  Random-peptide libraries and antigen-fragment libraries for epitope mapping and the development of vaccines and diagnostics.

Authors:  M B Irving; O Pan; J K Scott
Journal:  Curr Opin Chem Biol       Date:  2001-06       Impact factor: 8.822

7.  Investigation of osteopontin levels and genomic variation of osteopontin and its receptors in Type 1 diabetes mellitus.

Authors:  Z Karamizadeh; E Kamali Sarvestani; F Saki; H Karamifar; G H Amirhakimi; M H Namavar Shooshtarian; S Ashkani-Esfahani
Journal:  J Endocrinol Invest       Date:  2013-09-27       Impact factor: 5.467

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.